Radionetics Oncology

Radionetics Oncology is a biopharmaceutical company dedicated to the discovery and development of innovative radiotherapeutics aimed at treating various oncology indications. The company specializes in creating non-peptide and small molecule agents that facilitate the delivery of therapeutic radioisotopes, targeting solid tumors. By advancing these novel treatments, Radionetics Oncology aims to enhance the options available to medical professionals in combating cancer.

Paul Grayson

CEO and President

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.